These results are consistent with multiple published studies demonstrating that LCIS is associated with inactivation and disruption of the entire E-cadherin complex, including alpha-catenin, beta-catenin and p120-catenin [22-25]. The gene discussed is CTNND1; the disease is lobular breast carcinoma in situ.